AMPHNasdaq United States
Market cap
$916.251 M
$20.78 +4.90%
Close of 7 Aug 2026
Revenue
$719.9M
#1725 by revenue
Earnings
$98.1M
#1326 by earnings
Shares outstanding
42,537,944
Latest filing cover page
P/E ratio
9.3
Cap ÷ net income
Where these numbers come from
Share counts and financials for Amphastar Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.